Sirtuins and SIRT6 in carcinogenesis and in diet

dc.contributor.authorde Céu Teixeira, Mariapor
dc.contributor.authorSanchez-Lopez, Elenapor
dc.contributor.authorEspina, Martapor
dc.contributor.authorGarcia, Maria Luisapor
dc.contributor.authorDurazzo, Alessandrapor
dc.contributor.authorLucarini, Massimopor
dc.contributor.authorNovellino, Ettorepor
dc.contributor.authorSouto, Selma B.por
dc.contributor.authorSantini, Antonellopor
dc.contributor.authorSouto, Eliana B.por
dc.date.accessioned2019-10-14T09:44:23Z
dc.date.available2019-10-14T09:44:23Z
dc.date.issued2019-10-07
dc.date.updated2019-10-11T15:51:16Z
dc.description.abstractSirtuins are a highly conserved family of nicotinamide adenine dinucleotide (NAD)-dependent protein lysine modifying enzymes. They are key regulators for a wide variety of cellular and physiological processes such as cell proliferation, differentiation, DNA damage and stress response, genome stability, cell survival, metabolism, energy homeostasis, organ development and aging. Aging is one of the major risk factors of cancer, as many of the physiological mechanisms and pathologies associated with the aging process also contribute to tumor initiation, growth and/or metastasis. This review focuses on one the mammalian sirtuins, SIRT6, which has emerged as an important regulator of longevity and appears to have multiple biochemical functions that interfere with tumor development and may be useful in cancer prevention and for site-specific treatment. The recent evidence of the role of SIRT6 in carcinogenesis is also discussed, focusing on the potential use of SIRT6 modulators in cancer nanomedicine.por
dc.description.sponsorshipThe authors would like to thank the financial support received from the Portuguese Science and Technology Foundation (FCT/MCT) and from European Funds (PRODER/COMPETE) under the project reference M-ERA-NET/0004/2015-PAIRED, co-financed by FEDER, under the Partnership Agreement PT2020. MCT wishes to acknowledge FCT and Dendropharma - Investigação E Serviços De Intervenção Farmacêutica, Sociedade Unipessoal Lda, for the individual fellowship (PDE/00017/2013). The Institute of Nanoscience and Nanotechnology is also acknowledged (project ART2018).por
dc.distributioninternationalpor
dc.identifier.doi10.3390/ijms20194945por
dc.identifier.issn1661-6596por
dc.identifier.pmid31591350por
dc.identifier.urihttps://hdl.handle.net/1822/61785
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherMultidisciplinary Digital Publishing Institutepor
dc.relation.publisherversionhttps://www.mdpi.com/1422-0067/20/19/4945por
dc.rightsopenAccesspor
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/por
dc.subjectsirtuinspor
dc.subjectSIRT6por
dc.subjectcancerpor
dc.subjectmodulatorpor
dc.subjectchemotherapypor
dc.subjectdietpor
dc.subject.wosScience & Technologypor
dc.titleSirtuins and SIRT6 in carcinogenesis and in dietpor
dc.typearticlepor
dspace.entity.typePublicationen
oaire.citationIssue19por
oaire.citationVolume20por
oaire.versionVoRpor
sdum.journalInternational Journal of Molecular Sciencespor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
ijms-20-04945-v2.pdf
Tamanho:
702.56 KB
Formato:
Adobe Portable Document Format